Annual Shareholders Equity
-$14.46 M
-$69.77 M-126.14%
December 31, 2023
Summary
- As of February 12, 2025, EIGR annual stockholders equity is -$14.46 million, with the most recent change of -$69.77 million (-126.14%) on December 31, 2023.
- During the last 3 years, EIGR annual shareholders equity has fallen by -$109.49 million (-115.21%).
- EIGR annual shareholders equity is now -115.21% below its all-time high of $95.03 million, reached on December 31, 2020.
Performance
EIGR Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
-$14.46 M
-$12.85 M-801.37%
December 31, 2023
Summary
- As of February 12, 2025, EIGR quarterly stockholders equity is -$14.46 million, with the most recent change of -$12.85 million (-801.37%) on December 31, 2023.
- Over the past year, EIGR quarterly shareholders equity has dropped by -$69.77 million (-126.14%).
- EIGR quarterly shareholders equity is now -111.46% below its all-time high of $126.19 million, reached on March 31, 2021.
Performance
EIGR Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
EIGR Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -126.1% | -126.1% |
| 3 y3 years | -115.2% | -115.2% |
| 5 y5 years | -121.7% | -121.7% |
EIGR Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -120.0% | at low | -114.0% | at low |
| 5 y | 5-year | -115.2% | at low | -111.5% | at low |
| alltime | all time | -115.2% | +79.6% | -111.5% | at low |
Eiger BioPharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | -$14.46 M(-126.1%) | -$14.46 M(+801.4%) |
| Sep 2023 | - | -$1.60 M(-110.5%) |
| Jun 2023 | - | $15.29 M(-56.6%) |
| Mar 2023 | - | $35.24 M(-36.3%) |
| Dec 2022 | $55.31 M(-23.6%) | $55.31 M(-29.4%) |
| Sep 2022 | - | $78.31 M(-23.9%) |
| Jun 2022 | - | $102.92 M(+5.8%) |
| Mar 2022 | - | $97.27 M(+34.3%) |
| Dec 2021 | $72.40 M(-23.8%) | $72.40 M(-19.1%) |
| Sep 2021 | - | $89.47 M(-18.0%) |
| Jun 2021 | - | $109.13 M(-13.5%) |
| Mar 2021 | - | $126.19 M(+32.8%) |
| Dec 2020 | $95.03 M(+68.3%) | $95.03 M(+2.2%) |
| Sep 2020 | - | $92.95 M(+58.9%) |
| Jun 2020 | - | $58.49 M(+35.3%) |
| Mar 2020 | - | $43.22 M(-23.5%) |
| Dec 2019 | $56.48 M(-15.2%) | $56.48 M(-21.2%) |
| Sep 2019 | - | $71.66 M(-18.6%) |
| Jun 2019 | - | $88.08 M(+73.4%) |
| Mar 2019 | - | $50.81 M(-23.7%) |
| Dec 2018 | $66.59 M | $66.59 M(+97.2%) |
| Sep 2018 | - | $33.77 M(-31.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2018 | - | $49.28 M(+234.5%) |
| Mar 2018 | - | $14.73 M(-34.6%) |
| Dec 2017 | $22.52 M(-44.7%) | $22.52 M(+79.4%) |
| Sep 2017 | - | $12.55 M(-39.3%) |
| Jun 2017 | - | $20.67 M(-33.0%) |
| Mar 2017 | - | $30.87 M(-24.2%) |
| Dec 2016 | $40.72 M(+29.1%) | $40.72 M(-21.8%) |
| Sep 2016 | - | $52.06 M(+18.4%) |
| Jun 2016 | - | $43.97 M(-18.2%) |
| Mar 2016 | - | $53.75 M(+70.3%) |
| Dec 2015 | $31.55 M(-56.2%) | $31.55 M(-13.3%) |
| Sep 2015 | - | $36.41 M(-15.0%) |
| Jun 2015 | - | $42.82 M(-26.3%) |
| Mar 2015 | - | $58.10 M(-19.4%) |
| Dec 2014 | $72.10 M(+691.7%) | $72.10 M(-12.0%) |
| Sep 2014 | - | $81.97 M(+68.8%) |
| Jun 2014 | - | $48.56 M(-11.0%) |
| Mar 2014 | - | $54.58 M(+499.3%) |
| Dec 2013 | $9.11 M(-61.8%) | $9.11 M(-57.2%) |
| Sep 2013 | - | $21.29 M(+4.0%) |
| Jun 2013 | - | $20.47 M |
| Dec 2012 | $23.86 M(-133.6%) | - |
| Dec 2011 | -$70.98 M | - |
FAQ
- What is Eiger BioPharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals annual shareholders equity year-on-year change?
- What is Eiger BioPharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Eiger BioPharmaceuticals?
- What is Eiger BioPharmaceuticals quarterly shareholders equity year-on-year change?
What is Eiger BioPharmaceuticals annual stockholders equity?
The current annual shareholders equity of EIGR is -$14.46 M
What is the all time high annual shareholders equity for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high annual stockholders equity is $95.03 M
What is Eiger BioPharmaceuticals annual shareholders equity year-on-year change?
Over the past year, EIGR annual stockholders equity has changed by -$69.77 M (-126.14%)
What is Eiger BioPharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of EIGR is -$14.46 M
What is the all time high quarterly shareholders equity for Eiger BioPharmaceuticals?
Eiger BioPharmaceuticals all-time high quarterly stockholders equity is $126.19 M
What is Eiger BioPharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, EIGR quarterly stockholders equity has changed by -$69.77 M (-126.14%)